A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
Clinical trial NCT05110846 · COMPLETED
Trial details
- NCT number
- NCT05110846
- Sponsor
- Carmot Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2023-02-28
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.